Finally, the comparison between MS and HS pinpointed four up-regulated proteins (sTNF-R2, CCL24, MMP-1, and CCL22) and one down-regulated protein (IFNα2) in MS patients. This evidence concerns the gene CCL22 and myeloid sarcoma.